September 23, 2021 08:29 AM EDTUpdated September 29, 09:05 AM

Covid-19 manufacturing roundup: Bharat Biotech turns to other producers to up supply; Brazil, Argentina land mRNA regional hubs

Josh Sullivan

Bharat Biotech is ready to start manufacturing doses of its Covid-19 vaccine — named Covaxin — at an associate firm’s Manjari site, Business-Standard

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 manufacturing roundup: Bharat Biotech turns to other producers to up supply; Brazil, Argentina land mRNA regional hubs

Josh Sullivan

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Breaking down silos with a new quantitative approach to drug development

Covid-19 man­u­fac­tur­ing roundup: Bharat Biotech turns to oth­er pro­duc­ers to up sup­ply; Brazil, Ar­genti­na land mR­NA re­gion­al hubs

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Covid-19 manufacturing roundup: Bharat Biotech turns to other producers to up supply; Brazil, Argentina land mRNA regional hubs